ST. CHARLES PHARMACEUTICALS

Basic Information

650 Poydras St, Suite 2830
New Orleans, LA, 70130

Company Profile

n/a

Additional Details

Field Value
DUNS: 603023529
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Non-Narcotic Intravenous Analgesics

    Amount: $111,893.00

    DESCRIPTION (provided by applicant): Intravenous drug administration is often clinically desired over oral administration, particularly for patients who have difficulty taking an oral drug due to thei ...

    SBIR Phase I 2007 Department of Health and Human Services
  2. Preclinical Development of SCP-123 for Neuropathic Pain

    Amount: $636,256.00

    DESCRIPTION (provided by applicant): Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain s ...

    SBIR Phase II 2007 Department of Health and Human Services
  3. Novel drug combinations for the management of pain

    Amount: $789,210.00

    DESCRIPTION (provided by applicant): The therapeutic use of some analgesic compounds is often limited because of potentially adverse and dangerous side effects. However, combinations of analgesics wit ...

    SBIR Phase II 2005 Department of Health and Human Services
  4. Novel Analgesics for the Treatment of Bone Cancer Pain

    Amount: $109,305.00

    DESCRIPTION (provided by applicant): Pain is the most prevalent symptom in cancer patients, and bone metastasis is one of the most common sources of cancer-related pain. In the 3-step guidelines estab ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. Development of SCP-1 to Treat Pain in the Elderly

    Amount: $0.00

    DESCRIPTION (provided by applicant): Acetaminophen is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances, pain needs to be ...

    STTR Phase I 2003 Department of Health and Human Services
  6. Development of SCP-1 to Treat Pain in the Elderly

    Amount: $499,068.00

    DESCRIPTION (provided by applicant): Acetaminophen is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances, pain needs to be ...

    STTR Phase II 2003 Department of Health and Human Services
  7. Novel Drug Combinations for Treating Pain in the Elderly

    Amount: $99,959.00

    DESCRIPTION (provided by applicant): Combination analgesics, including acetaminophen with opioids, are used extensively for pain management in the elderly (and others). This is, in part, because these ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. Development of SCP-1/opioid combinations for pain

    Amount: $99,947.00

    DESCRIPTION (provided by applicant): Combinations of acetaminophen with opioids (i.e., hydrocodone, codeine) are frequently prescribed for acute and chronic pain management. Combinations of analgesics ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. Pain Relieving Properties of Analgesic Metabolites

    Amount: $99,278.00

    DESCRIPTION (provided by applicant): Acetaminophen is used extensively in the management of mild to moderate pain. Even so, acetaminophen can cause hepatotoxicty after ingestion of large doses or from ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. DEVELOPMENT OF NOVEL THERAPEUTICS FOR POSTSURGICAL PAIN

    Amount: $0.00

    Acetaminophen and NSAIDs have been used routinely for treatment of pain and/or fever. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking symp ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government